menu
    • menu
    [{"orgOrder":0,"company":"Purdue Pharmaceuticals L.P","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Undisclosed","year":"2014","type":"Inapplicable","leadProduct":"Water","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Purdue Pharmaceuticals L.P","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Purdue Pharmaceuticals L.P \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Purdue Pharmaceuticals L.P \/ Undisclosed"},{"orgOrder":0,"company":"University of South Carolina","sponsor":"HydraVes Technologies Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Water","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"University of South Carolina","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of South Carolina \/ HydraVes Technologies Inc.","highestDevelopmentStatusID":"1","companyTruncated":"University of South Carolina \/ HydraVes Technologies Inc."},{"orgOrder":0,"company":"Danone Global Research & Innovation Center","sponsor":"Region Skane","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Dietary Supplement","year":"2018","type":"Inapplicable","leadProduct":"Water","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Danone Global Research & Innovation Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Danone Global Research & Innovation Center \/ Region Skane","highestDevelopmentStatusID":"1","companyTruncated":"Danone Global Research & Innovation Center \/ Region Skane"},{"orgOrder":0,"company":"Danone Global Research & Innovation Center","sponsor":"Region Skane","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"FRANCE","productType":"Dietary Supplement","year":"2018","type":"Inapplicable","leadProduct":"Water","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Danone Global Research & Innovation Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Danone Global Research & Innovation Center \/ Region Skane","highestDevelopmentStatusID":"1","companyTruncated":"Danone Global Research & Innovation Center \/ Region Skane"}]

    Find Clinical Drug Pipeline Developments & Deals for Bacteriostatic water for injection in plastic container

    Menu

    Bacteriostatic water for injection in plastic container

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            University of South Carolina

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            University of South Carolina

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Water

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : HydraVes Technologies Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effect of Proprietary Water on Physiological and Perceptual Responses

                            Details : Water is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Dehydration.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 11, 2022

                            Lead Product(s) : Water

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : HydraVes Technologies Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Danone Global Research & Innovation Center

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Danone Global Research & Innovation Center

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Water

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Region Skane

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Hydration to Optimize Metabolism (H2O Metabolism) Pilot Study

                            Details : Water is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Dehydration.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 02, 2018

                            Lead Product(s) : Water

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Region Skane

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Danone Global Research & Innovation Center

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Danone Global Research & Innovation Center

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Water

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Region Skane

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Hydration to Optimize Metabolism

                            Details : Water is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Hyperglycemia.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            February 06, 2018

                            Lead Product(s) : Water

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Region Skane

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Purdue Pharmaceuticals L.P

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Purdue Pharmaceuticals L.P

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Water

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subj...

                            Details : HYD is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            September 17, 2014

                            Lead Product(s) : Water

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth